{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:53:05Z","timestamp":1782489185905,"version":"3.54.5"},"reference-count":26,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research network on Chronicity, Primary Care and Health promotion","award":["RD21\/0016\/0009"],"award-info":[{"award-number":["RD21\/0016\/0009"]}]},{"name":"Spanish Ministry of Economy and Competitiveness, Carlos III Institute","award":["PI22\/01669"],"award-info":[{"award-number":["PI22\/01669"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Potentially inappropriate prescriptions (PIPs) in older adults, such as long-term use of benzodiazepines, proton pump inhibitors without indication or antipsychotics in dementia, are associated with adverse events and increased healthcare utilisation. Despite clinical guidelines discouraging their use, PIPs remain frequent in primary care. An audit and feedback (A&amp;F) intervention of PIPs to general practitioners (GPs), led by pharmacists, may reduce the prescription of PIPs in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A two-arm, pragmatic, controlled trial will be conducted to evaluate the effectiveness of an A&amp;F-based intervention and a pharmacist-led intervention to reduce the proportion of patients aged \u226565 years receiving inappropriate prescriptions. A total of 170 participating GPs, 85 per group, are required. GPs will be randomised into intervention or control groups (1:1). The intervention includes feedback reports, pharmacist-led academic detailing and access to online training modules. The primary outcome is the proportion of older adults receiving at least one PIP at 12\u2009months as well as the total number of PIPs. A random effects Tobit regression model, censored at 0 and 100, will be used to estimate between-group differences adjusted for baseline prescribing. Subgroup analyses will explore heterogeneity of effect by baseline prescribing level and healthcare region. Implementation outcomes, including reach, fidelity, engagement and maintenance, will be evaluated using the Reach, Effectiveness, Adoption, Implementation and Maintenance framework, combining quantitative and qualitative data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval was obtained by the Balearic Island Committee Ethics (IB5219\/23PI). Study findings, including primary and secondary outcomes and qualitative implementation results, will be disseminated through peer-reviewed publications and stakeholder reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN14449434\">ISRCTN14449434<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-104877","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:30:23Z","timestamp":1778081423000},"page":"e104877","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"isrctn14449434","registry":"10.18810\/isrctn"}],"author":[{"given":"Alfonso","family":"Leiva","sequence":"first","affiliation":[{"name":"Balearic Islands Health Research Institute, Balearic Islands Health Research Institute (IdISBa), Palma, Illes Balears, Spain"},{"name":"Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Palma, Illes Balears, Spain"},{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5769-706X","authenticated-orcid":false,"given":"Laura","family":"Gallardo Alfaro","sequence":"additional","affiliation":[{"name":"Balearic Islands Health Research Institute, Balearic Islands Health Research Institute (IdISBa), Palma, Illes Balears, Spain"},{"name":"Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Palma, Illes Balears, Spain"},{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Bejarano","sequence":"additional","affiliation":[{"name":"GAPiC Camp de Tarragona, Catalan Health Institute (Institut Catal\u00e0 de la Salut), Tarragona, Spain"},{"name":"Emerging Research Group on Health Interventions and Community Activities (GRE ISAC; 2021 SGR 00884), Catalunya, Spain"},{"name":"Research Group on Quality and Patient Safety of Tarragona (2022 6G22\/035), Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermengol","family":"Sempere","sequence":"additional","affiliation":[{"name":"Paterna Health Centre, Department of Health, Generalitat Valenciana, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Soler","sequence":"additional","affiliation":[{"name":"Balearic Islands Health Research Institute, Balearic Islands Health Research Institute (IdISBa), Palma, Illes Balears, Spain"},{"name":"Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Palma, Illes Balears, Spain"},{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Huguet","sequence":"additional","affiliation":[{"name":"Balearic Islands Health Research Institute, Balearic Islands Health Research Institute (IdISBa), Palma, Illes Balears, Spain"},{"name":"Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Palma, Illes Balears, Spain"},{"name":"Research Group on Global Health, University of Balearic Islands, Palma, Spain"},{"name":"Research Group on Nursing, Community and Global Health, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain"},{"name":"Nursing and Physiotherapy Department, University of the Balearic Islands, Palma, Islas Baleares, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Llarena","sequence":"additional","affiliation":[{"name":"Biobizkaia Health Research Institute, Barakaldo, Spain"},{"name":"Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itxasne","family":"Lekue","sequence":"additional","affiliation":[{"name":"Biobizkaia Health Research Institute, Barakaldo, Spain"},{"name":"Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Bilbao, Spain"},{"name":"Primary Care Pharmacy Unit, Ezkerraldea-Enkarterri-Cruces Integrated Health Organization, Osakidetza-Basque Health Service, Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia","family":"Campabadal Prats","sequence":"additional","affiliation":[{"name":"GAPiC Camp de Tarragona, Catalan Health Institute (Institut Catal\u00e0 de la Salut), Tarragona, Spain"},{"name":"Research Group on Mental Health and Primary Care (2022 6G22\/055), Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Salom","sequence":"additional","affiliation":[{"name":"GAPiC Camp de Tarragona, Catalan Health Institute (Institut Catal\u00e0 de la Salut), Tarragona, Spain"},{"name":"Research Group on Mental Health and Primary Care (2022 6G22\/055), Catalunya, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo Broseta","family":"Solaz","sequence":"additional","affiliation":[{"name":"Arnau de Vilanova\u2013Ll\u00edria Health Department, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Socias Ca\u00f1ellas","sequence":"additional","affiliation":[{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agusti","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem Marc","family":"Campins","sequence":"additional","affiliation":[{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vanrell","sequence":"additional","affiliation":[{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rovira","sequence":"additional","affiliation":[{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Ponsa Mir","sequence":"additional","affiliation":[{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Vicens-Caldentey","sequence":"additional","affiliation":[{"name":"Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Palma, Illes Balears, Spain"},{"name":"Primary Care Management of Mallorca, Balearic Health Service, Palma, Spain"},{"name":"Son Serra-La Vileta Health Centre, Balearic health Service, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2026062608310930000_16.5.e104877.1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12596"},{"key":"2026062608310930000_16.5.e104877.2","unstructured":"Medication without harm. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIS-SDS-2017.6 [Accessed 30 Apr 2025]."},{"key":"2026062608310930000_16.5.e104877.3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J American Geriatrics Society"},{"key":"2026062608310930000_16.5.e104877.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0324-2"},{"key":"2026062608310930000_16.5.e104877.5","first-page":"543","article-title":"Potenziell inad\u00e4quate medikation f\u00fcr \u00e4ltere menschen: Die PRISCUS-liste","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch Arztebl"},{"key":"2026062608310930000_16.5.e104877.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-011-0061-5"},{"key":"2026062608310930000_16.5.e104877.7","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-023-00777-y"},{"key":"2026062608310930000_16.5.e104877.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1860-9"},{"key":"2026062608310930000_16.5.e104877.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4524","article-title":"Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study","volume":"363","author":"P\u00e9rez","year":"2018","journal-title":"BMJ"},{"key":"2026062608310930000_16.5.e104877.10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.17988","article-title":"Potentially Inappropriate Medication Use in Primary Care in Switzerland","volume":"7","author":"Schietzel","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026062608310930000_16.5.e104877.11","unstructured":"OECD Data Explorer . Pharmaceutical consumption. Available: https:\/\/data- explorer.oecd.org [Accessed 30 Apr 2025]."},{"key":"2026062608310930000_16.5.e104877.12","first-page":"43","article-title":"Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines","volume":"129","author":"Lee","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"2026062608310930000_16.5.e104877.13","first-page":"354","article-title":"Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"2026062608310930000_16.5.e104877.14","unstructured":"Bjerre LM , Farrell B , Hogel M , et al . D\u00e9prescription des antipsychotiques pour les sympt\u00f4mes comportementaux et psychologiques de la d\u00e9mence et l\u2019insomnie. Canadian Fam Physician 2018;64."},{"key":"2026062608310930000_16.5.e104877.15","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12732"},{"key":"2026062608310930000_16.5.e104877.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081934","article-title":"Pharmacist-led primary care interventions to promote medicines optimisation and reduce overprescribing: a systematic review of UK studies and initiatives","volume":"14","author":"Chambers","year":"2024","journal-title":"BMJ Open"},{"key":"2026062608310930000_16.5.e104877.17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/fampra\/cmac150","article-title":"Audit and feedback interventions involving pharmacists to influence prescribing behaviour in general practice: a systematic review and meta-analysis","volume":"40","author":"Carter","year":"2023","journal-title":"Fam Pract"},{"key":"2026062608310930000_16.5.e104877.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253588","article-title":"Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis","volume":"16","author":"Jaam","year":"2021","journal-title":"PLoS One"},{"key":"2026062608310930000_16.5.e104877.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.21022"},{"key":"2026062608310930000_16.5.e104877.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-11-201006010-00232"},{"key":"2026062608310930000_16.5.e104877.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"2026062608310930000_16.5.e104877.22","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.89.9.1322"},{"key":"2026062608310930000_16.5.e104877.23","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-010-0319-7"},{"key":"2026062608310930000_16.5.e104877.24","article-title":"Audit and feedback: effects on professional practice and healthcare outcomes","volume":"2012","author":"Ivers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026062608310930000_16.5.e104877.25","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(11)61817-5","article-title":"A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis","volume":"379","author":"Avery","year":"2012","journal-title":"The Lancet"},{"key":"2026062608310930000_16.5.e104877.26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ehjqcco\/qcae045","article-title":"The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis","volume":"10","author":"Kefale","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-104877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:38:31Z","timestamp":1782488311000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-104877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,6]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2025-104877"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-104877","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}